Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on September 13, 2004

Circulation. 2004
Published online before print September 13, 2004, doi: 10.1161/01.CIR.0000143072.36782.51
A more recent version of this article appeared on September 28, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/13/1787    most recent
01.CIR.0000143072.36782.51v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, S.
Right arrow Articles by Ogawa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, S.
Right arrow Articles by Ogawa, H.
Related Collections
Right arrow Congestive
Right arrow Physiological and pathological control of gene expression

Submitted on August 9, 2002
Revised on May 7, 2004
Accepted on June 17, 2004

Possible Association of Heart Failure Status With Synthetic Balance Between Aldosterone and Dehydroepiandrosterone in Human Heart

Shota Nakamura MD, Michihiro Yoshimura MD, PhD*, Masafumi Nakayama MD, PhD, Teruhiko Ito MD, PhD, Yuji Mizuno MD, PhD, Eisaku Harada MD, PhD, Tomohiro Sakamoto MD, PhD, Yoshihiko Saito MD, PhD, Kazuwa Nakao MD, PhD, Hirofumi Yasue MD, PhD, and Hisao Ogawa MD, PhD

From the Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University (S.N., M.Y., M.N., T.S., H.O.), Kumamoto, Japan; the Division of Cardiology, Kumamoto Aging Research Institute (T.I., Y.M., E.H., H.Y.), Kumamoto, Japan; the First Department of Internal Medicine, Nara Medical University (Y.S.), Nara, Japan; and the Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine (K.N.), Kyoto, Japan.

* To whom correspondence should be addressed. E-mail: bnp{at}kumamoto-u.ac.jp.

Background--Aldosterone is produced not only in the adrenal gland but also in the extra-adrenal tissues, including failing human heart. This study examined the production of dehydroepiandrosterone (DHEA) in human heart and elucidated the possible physiological significance.

Method and Results--Using left ventricular tissues obtained at autopsy, reverse transcription-polymerase chain reaction followed by Southern blot analysis revealed the gene expressions of CYP17. By measuring plasma aldosterone and DHEA levels at the coronary sinuses and aortic roots during cardiac catheterization, we found that DHEA but not aldosterone was secreted from control subjects (P<0.0001 and P=0.74, respectively), whereas aldosterone but not DHEA was secreted from patients with heart failure (P=0.0017 and P=0.67, respectively). To examine the significance of DHEA, we measured myocyte cell sizes and the gene expression of B-type natriuretic peptide (BNP), using a neonatal rat cardiocyte culture system. We found that DHEA (10-8 mol/L) significantly inhibited the increase in myocyte cell sizes and BNP mRNA levels upregulated by endothelin-1 (P=0.031 and P<0.0001, respectively).

Conclusions--CYP17 gene expression and production of DHEA were demonstrated in human control heart. Also, we found that cardiac production of DHEA was suppressed in failing heart. We postulated that DHEA and/or its metabolites exert a cardioprotective action through antihypertrophic effects.


Key words: heart failure • hormones • hypertrophy • cardiomyopathy • natriuretic peptides




This article has been cited by other articles:


Home page
JAMAHome page
E. A. Jankowska, P. Rozentryt, B. Ponikowska, O. Hartmann, D. Kustrzycka-Kratochwil, K. Reczuch, J. Nowak, L. Borodulin-Nadzieja, L. Polonski, W. Banasiak, et al.
Circulating Estradiol and Mortality in Men With Systolic Chronic Heart Failure
JAMA, May 13, 2009; 301(18): 1892 - 1901.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Aragno, R. Mastrocola, G. Alloatti, I. Vercellinatto, P. Bardini, S. Geuna, M. G. Catalano, O. Danni, and G. Boccuzzi
Oxidative Stress Triggers Cardiac Fibrosis in the Heart of Diabetic Rats
Endocrinology, January 1, 2008; 149(1): 380 - 388.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Aragno, R. Mastrocola, C. Medana, M. G. Catalano, I. Vercellinatto, O. Danni, and G. Boccuzzi
Oxidative Stress-Dependent Impairment of Cardiac-Specific Transcription Factors in Experimental Diabetes
Endocrinology, December 1, 2006; 147(12): 5967 - 5974.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. Chai, I. M. Garrelds, R. de Vries, and A.H. Jan Danser
Cardioprotective Effects of Eplerenone in the Rat Heart: Interaction With Locally Synthesized or Blood-Derived Aldosterone?
Hypertension, April 1, 2006; 47(4): 665 - 670.
[Abstract] [Full Text] [PDF]